Literature DB >> 820630

Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

A Martin, P J Lachmann, L Halbwachs, M J Hobart.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 820630     DOI: 10.1016/0019-2791(76)90341-4

Source DB:  PubMed          Journal:  Immunochemistry        ISSN: 0019-2791


× No keyword cloud information.
  53 in total

1.  Complement, complement activation and anaphylatoxins in human ovarian follicular fluid.

Authors:  R Perricone; C de Carolis; C Moretti; E Santuari; G de Sanctis; L Fontana
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Purification of cobra venom factor from phospholipase A contaminant.

Authors:  P J Lachmann; L Halbwachs; A Gewurz; H Gewurz
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

3.  Mechanism of complement activation by radiographic contrast media.

Authors:  C M Arroyave; E M Tan
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

4.  Heterogeneity of nephritic factor and its identification as an immunoglobulin.

Authors:  A E Davis; J B Ziegler; E W Gelfand; F S Rosen; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Human C4 polymorphism: pedigree analysis of qualitative, quantitative, and functional parameters as a basis for phenotype interpretations.

Authors:  G Mauff; K Bender; C M Giles; S Goldmann; W Opferkuch; B Wachauf
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  The chemical mediation of delayed hypersensitivity skin reactions. IV. Activation of chemotactic factor precursor by a trypsin-like protease in guinea pig plasma.

Authors:  T Kawaguchi; K Ueda; T Yamamoto; T Kambara
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

7.  Metabolism of human beta 1H: studies in man and experimental animals.

Authors:  J A Charlesworth; D M Scott; B A Pussell; D K Peters
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

8.  C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.

Authors:  A T Gewurz; S M Imherr; S Strauss; H Gewurz; C Mold
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

9.  Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A.

Authors:  S W Vukajlovich
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

10.  Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.

Authors:  M T Aguado; L H Perrin; R Ramirez; P A Miescher; P H Lambert
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.